Help Cancer Patients Access Medications!

by Advita Fund USA
Help Cancer Patients Access Medications!
Help Cancer Patients Access Medications!
Help Cancer Patients Access Medications!
Help Cancer Patients Access Medications!
Help Cancer Patients Access Medications!
Help Cancer Patients Access Medications!
Help Cancer Patients Access Medications!
Help Cancer Patients Access Medications!
Help Cancer Patients Access Medications!
Help Cancer Patients Access Medications!

The holiday season is here!  This is a great time to pause and give thanks to those who have been supporting us for years - we know that without you we could never achieve what we have.  Please know that we are truly grateful for having you on our side! 

If you would like to support our project again this year, a great opportunity is coming soon - on Giving Tuesday, November 30th. This is an annual event to celebrate charity, community, and human kindness.  GlobalGiving will mark the day by giving away $1 million in bonus funds, to be divided proportionally among all the donations (up to $2,500 per donor) made on that day.  GlobalGiving will also add 100% bonuses to those donors who sign up for new monthly donations (up to $200 per donor). 

Your donations will go to buy Foscavir, a medication used to treat viral infections.  It is an important drug for immunosuppressed cancer patients undergoing bone marrow transplants or high-dose chemotherapy that brings down patients' immune system.  Foscavir is not registered in Russia and for this reason cannot be purchased inside Russia. The hospitals rely on charities' help to bring the medication to the patients from abroad.   The hospitals have to have the medication on hand, because it has to be administered within days, or sometimes hours, to get the infection under control. 

Thanks to your support, we were able to spend $9,719 this year and support 7 patients.  We hope that with your help we can do even more before the end of the year.  Thanks again for staying with us and hope to hear from you on Giving Tuesday!

 

Share on Twitter Share on Facebook

Our project has been helping Muazzam with lifesaving medications since 2017. We first learned about her story from her sister who has been her biggest supporter and advocate. 

Muazzam was diagnosed with Hodgkin's lymphoma in 2014, when she was just 27.  Most of Hodgkin's lymphoma patients get cured with standard chemotherapy, but a minority struggle to overcome their cancer for years. Muazzam was one of the unlucky ones.

At first she was treated locally, in her native Tajikistan.  Unfortunately, she was not able to complete her standard treatment protocol due to financial difficulties and severe side effects of chemotherapy.  Then two years later she was diagnosed with disease relapse when she traveled for an examination to Russia.  Muazzam started treatment right away, but then had to return home for radiation therapy since it was too expensive to pay for out of pocket. 

Yet the treatment at home could not be finished once again because the local doctors decided against radiation.  At that point Muazzam traveled to St. Petersburg to get a second opinion.  There she was recommended a new drug, nivolumab, that was shown to be highly effective for patients like her.  She finally achieved remission in 2018 and continued to stay on the medication to keep her disease under control.  From time to time, she travels to St. Peterburg for follow up and to refill her prescriptions.  Nivolumab is still unavailable in Tajikistan, like many other modern cancer drugs. 

Our project is most valuable for patients like Muazzam, for whom lifesaving medications are available, but only if they are aware that they exist and are able to access them.  Our mission is to bridge the gaps in access to medications for the patients in the former Soviet Union.  With your support, we can continue to help patients like Muazzam.  Thank you!  

Share on Twitter Share on Facebook

Etoposide is one the essential cancer drugs, a chemotherapy medication used for the treatments of a number of types of cancer including lung cancer, lymphoma, leukemia, neuroblastoma, and ovarian cancer. In use since 1980s, it had disappeared from Russian hospitals in the recent years.  New regulations effectively blocked foreign suppliers from importing medications if there are domestic manufacturers.  In reality, however, Russian pharma companies have been unable to meet demand for this and other drugs, creating a severe shortage of critically important drugs in the hospitals. 

As a result, cancer patients have been left on their own and forced to find and purchase their own medications.  Parents of children with cancer have been chasing medications all over the country or buying them off the black market. 

We are working with Advita fund in St. Peterburg to help them provide these critically important medications for their patients.  Recently, we have received a request for Eto-Gry (etoposide) for two of the young patients they support. We will be able to cover the bill from a European pharmacy for 5,000 euros thanks to your support and generosity. 

We appreciate your care for severely ill patients who are facing not just the struggle for their health but also disruptive actions of their government.  We will do everything in our power to suppor them and we know that with your help we can make a difference for many patients.

Thanks again!

Share on Twitter Share on Facebook

This year, each and every one of our lives has been turned upside down. Yet, in the midst of this uncertainty, the generosity of supporters like you has helped us to continue buying new and effective medications for cancer patients.  So far this year we have spent over $37,000 to support cancer patients in Russia and Ukraine! 

Unfortunately, at exactly this time each year the hospitals in Russia begin experiencing medication shortages as the system of quotas Russian healthcare employs is deeply flawed and inflexible.  Until late January or even February, many cancer patients are forced to search for medications on the market and buy them out of their own pockets or seek help from charities. 

No matter the obstacles, we’ll keep working to advance our mission in the months and years to come—but we will need your continued compassion. 

The week of December 14th, GlobalGiving will match all new monthly donations at 200%!

Start a monthly donation today: https://www.globalgiving.org/projects/help-cancer-patients-access-medications

If you are able to start a new monthly donation, you’ll provide vital stability, allowing us to focus less on day-to-day fundraising and more on supporting cancer patients. Even better, setting up an automatic monthly donation is safe and easy—and you can pause or cancel your monthly gift at any time.  You can view the full terms here.

Thank you for your generous support during these challenging times! Our team wishes you and your family well during this trying holiday season.

Share on Twitter Share on Facebook

As we are gradually adjusting to life during pandemic, we are still working through disruptions of supply chains and travel restrictions.  However, as patients continue needing our support with medications, we have to find ways to help them.

We have been recently asked by our sister charity, Advita Fund in St Petersburg, to help pay for an antifungal drug, Amphomoronal.  It is needed to treat children with cancer who come to St. Petersburg for treatment from all over Russia.  Patients with cancer who are treated with chemotherapy or receive a bone marrow transplant have an increased risk of picking up fungal infections. Such infections can be life-threatening. Antifungal drugs are designed to prevent or overcome these infections.

We are raising funds to purchase 100 packages of Amphomoronal that will be shipped to Russia from Germany.  It is not registered in Russia and has no domestic analogues.  The government-funded healthcare does not pay for this medication, which means it is left up to the charities to supply hospitals and patients with this drug.  Your support will help us ensure that children with cancer are able to access appropriate medications at the right time and in the right dosage. 

This week, you have a great opportunity to maximize your impact - Little by Little campaign that starts on Monday, Spetember 14th, will match at 50% all donations of up to $50 through Friday, September 18th!  And if you sign up for monthly donations, they will add on another 100% of your donation!  Thank you so much for staying with our project and supporting cancer patients!

Stay safe!

Share on Twitter Share on Facebook
 

About Project Reports

Project Reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.

If you donate to this project or have donated to this project, you will get an e-mail when this project posts a report. You can also subscribe for reports via e-mail without donating.

Get Reports via Email

We'll only email you new reports and updates about this project.

Organization Information

Advita Fund USA

Location: Houston, Texas - USA
Website:
Facebook: Facebook Page
Twitter: @advitausa
Project Leader:
Marina Ouano
President
Houston, Texas United States
$37,649 raised of $50,000 goal
 
653 donations
$12,351 to go
Donate Now
lock
Donating through GlobalGiving is safe, secure, and easy with many payment options to choose from. View other ways to donate

Advita Fund USA has earned this recognition on GlobalGiving:

Help raise money!

Support this important cause by creating a personalized fundraising page.

Start a Fundraiser

Learn more about GlobalGiving

Teenage Science Students
Vetting +
Due Diligence

Snorkeler
Our
Impact

Woman Holding a Gift Card
Give
Gift Cards

Young Girl with a Bicycle
GlobalGiving
Guarantee

Sign up for the GlobalGiving Newsletter

WARNING: Javascript is currently disabled or is not available in your browser. GlobalGiving makes extensive use of Javascript and will not function properly with Javascript disabled. Please enable Javascript and refresh this page.